Skip to content

HeartSciences Inc.: 10-Q filed 2025-12-15

What HeartSciences Inc. reported in its quarterly report filed 2025-12-15 (fiscal Q2 2025): 44 published measures, 112 facts as tagged in accession 0001193125-25-319203.

This filing

Form
10-Q (quarterly report)
Filed
2025-12-15
Fiscal period
fiscal Q2 2025
Accession
0001193125-25-319203 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HeartSciences Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-10-315,996,117USD
At 2025-04-304,222,909USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-10-311,813,647USD
At 2025-04-304,017,738USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-10-314,182,470USD
At 2025-07-313,141,111USD
At 2025-04-30205,171USD
At 2024-10-314,016,721USD
At 2024-07-315,933,958USD
At 2024-04-307,317,301USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-10-311,951,103USD
At 2025-04-301,098,098USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-08-01 to 2025-10-31-2,350,769USD92
2025-05-01 to 2025-10-31-4,405,763USD184
2024-08-01 to 2024-10-31-2,082,918USD92
2024-05-01 to 2024-10-31-4,134,607USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-05-01 to 2025-10-31-4,287,633USD184
2024-05-01 to 2024-10-31-4,202,270USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-05-01 to 2025-10-3113,030USD184
2024-05-01 to 2024-10-313,157USD184

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-08-01 to 2025-10-312,419USD92
2025-05-01 to 2025-10-314,319USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-05-01 to 2025-10-315,157,222USD184
2024-05-01 to 2024-10-312,453,417USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-05-01 to 2025-10-31-16,584USD184
2024-05-01 to 2024-10-31-6,675USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-10-31-80,533,398USD
At 2025-04-30-76,127,635USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-08-01 to 2025-10-312,780,496shares92
2025-05-01 to 2025-10-312,097,030shares184
2024-08-01 to 2024-10-31917,445shares92
2024-05-01 to 2024-10-31847,990shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-08-01 to 2025-10-312,780,496shares92
2025-05-01 to 2025-10-312,097,030shares184
2024-08-01 to 2024-10-31917,445shares92
2024-05-01 to 2024-10-31847,990shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-08-01 to 2025-10-31-0.85USD/shares92
2025-05-01 to 2025-10-31-2.1USD/shares184
2024-08-01 to 2024-10-31-2.27USD/shares92
2024-05-01 to 2024-10-31-4.88USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-08-01 to 2025-10-31-0.85USD/shares92
2025-05-01 to 2025-10-31-2.1USD/shares184
2024-08-01 to 2024-10-31-2.27USD/shares92
2024-05-01 to 2024-10-31-4.88USD/shares184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-10-3152,986USD
At 2025-04-3063,549USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-05-01 to 2025-10-31611,442USD184
2024-05-01 to 2024-10-3199,115USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-08-01 to 2025-10-31-2,073,403USD92
2025-05-01 to 2025-10-31-3,947,522USD184
2024-08-01 to 2024-10-31-1,985,033USD92
2024-05-01 to 2024-10-31-4,060,700USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-10-313,793,488USD
At 2025-04-302,171,457USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-10-311,566,384USD
At 2025-04-303,703,211USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-10-31317,390USD
At 2025-04-30318,661USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-10-311,629,307USD
At 2025-04-301,616,277USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-04-304,350USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-08-01 to 2025-10-312,074,814USD92
2025-05-01 to 2025-10-313,950,073USD184
2024-08-01 to 2024-10-311,985,033USD92
2024-05-01 to 2024-10-314,060,700USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-10-31657,285USD
At 2025-04-30650,267USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-08-01 to 2025-10-311,411USD92
2025-05-01 to 2025-10-312,551USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-08-01 to 2025-10-311,008USD92
2025-05-01 to 2025-10-311,768USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-08-01 to 2025-10-311,347,788USD92
2025-05-01 to 2025-10-312,225,841USD184
2024-08-01 to 2024-10-31786,068USD92
2024-05-01 to 2024-10-311,636,804USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-08-01 to 2025-10-31727,026USD92
2025-05-01 to 2025-10-311,724,232USD184
2024-08-01 to 2024-10-311,198,965USD92
2024-05-01 to 2024-10-312,423,896USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-10-313,071,135shares
At 2025-04-301,119,107shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-10-311,951,103USD
At 2025-04-301,098,098USD
At 2024-10-314,052,120USD
At 2024-04-305,807,648USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-10-3184,711,837USD
At 2025-04-3076,331,307USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-10-31321,633USD
At 2025-04-30371,626USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-10-31376,240USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-10-31604,461USD
At 2025-04-30600,907USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-10-31551,475USD
At 2025-04-30537,358USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-10-31311,184USD
At 2025-04-30506,307USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-05-01 to 2025-10-3114,117USD184
2024-05-01 to 2024-10-3124,079USD184

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-08-01 to 2025-10-31279,534USD92
2025-05-01 to 2025-10-31463,222USD184
2024-08-01 to 2024-10-31117,598USD92
2024-05-01 to 2024-10-31140,124USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-08-01 to 2025-10-31-277,366USD92
2025-05-01 to 2025-10-31-458,241USD184
2024-08-01 to 2024-10-31-97,885USD92
2024-05-01 to 2024-10-31-73,907USD184

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-05-01 to 2025-10-3113,129USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-05-01 to 2025-10-31-4,350USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-05-01 to 2025-10-317,018USD184
2024-05-01 to 2024-10-3123,728USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-05-01 to 2025-10-31-1,271USD184
2024-05-01 to 2024-10-31-171,335USD184

Inspect the source

Entity
HeartSciences Inc. / CIK 0001468492
Captured
2026-09-20T09:07:08.448Z
SEC response SHA-256
5eb1d09e2fca60365f9ba9d3f414c7100583b832746ccd0994084f9b163bc76c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001468492.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))